Concern over US commercial cancer genetic tests

5 July 2005

A US company, DNA Direct, is offering breast and ovarian cancer genetic susceptibility test kits for sale directly to the public (see Harding A (2005) BMJ 330, 617) for between $586 and $3312 (roughly

More from us